Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

Biotechnology

Healthcare
$16.62 +0.58%

+$0.04 today

Market cap
$3.04B
Beta
0.90
P/E (TTM)
98.7
EPS (TTM)
$0.07
52W Low $4.40High $10.08

Volume 2.56M

Average 1.66M

Fair Value & DCF

Compare our fair value with your own assumptions

Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.

Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

Intrinsic Alpha fair value

Locked

Current Price

$16.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.

Build your own valuation

Test an independent scenario and compare it with Intrinsic Alpha's estimate.

Sign in to use the DCF calculator

Free accounts get 5 valuations per week. Upgrade for more.

Sign in / Sign up

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
+230.7% (5yr)2 analysts
RevenueN/AN/A+38.3%
+25.2% (5yr)3 analysts
Net IncomeN/AN/AN/A
+230.5% (5yr)3 analysts
EBITN/AN/AN/A
+65.2% (5yr)3 analysts

Analysis

Recent growth has been strongest in Revenue at +38.3% over three years. Forward estimates point to EPS at +230.7% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Estimates & History

Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.

Further estimates hidden. Sign in to unlock

Competitor Valuations

Peer stocks ranked by intrinsic value status

CompanyMarket CapPriceValuationP/E1Y Return

Ascendis Pharma A/S

NASDAQ:ASND

$18.06B$275.39Not rated24.5+22.15%

Corcept Therapeutics Incorporated

NASDAQ:CORT

$7.98B$72.94Undervalued178.2-13.42%

MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

$2.78B$55.94Not rated-22.0+97.60%

Septerna, Inc.

NASDAQ:SEPN

$2.03B$42.60Undervalued-43.6+64.91%

Eton Pharmaceuticals, Inc.

NASDAQ:ETON

$1.84B$63.93Undervalued-597.6+276.44%

MannKind Corporation

NASDAQ:MNKD

$1.33B$4.13Overvalued-50.3-20.52%

GH Research PLC

NASDAQ:GHRS

$1.31B$19.10Not rated-23.8+32.67%

Spruce Biosciences, Inc.

NASDAQ:SPRB

$124.47M$43.31Not rated-1.9-60.54%